Status:
COMPLETED
The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer
Lead Sponsor:
Cyprus University of Technology
Collaborating Sponsors:
Bank of Cyprus Oncology Centre
Conditions:
Thyroid Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to determine whether the use of honey mouthwashes in the prevention of salivary side effects of 131I (radioiodine) therapy.
Eligibility Criteria
Inclusion
- \>18 years old
- They had a histological diagnosis of papillary, follicular, medullary or anaplastic thyroid cancer
- They had undergone total thyroidectomy
- They were able to provide consent
Exclusion
- patients who had distant metastases,
- a history of salivary-gland disorders,
- collagen tissue disease
- diabetes mellitus,
- previous radioiodine therapy or external radiation to the head or neck
- allergy to the honey
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01833650
Start Date
May 1 2013
End Date
September 1 2018
Last Update
September 25 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bank of Cyprus Oncology
Nicosia, Cyprus, 2006